Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Common stock and Paid-In Capital	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ 316,328		$ 759,432	$ (3,931)	$ (439,173)
Beginning Balance, Shares at Dec. 31, 2022		53,877,000
Stock issued under Employee Stock Purchase Plan, shares	0
Issuance of common stock upon vesting of restricted stock units shares		81,000
Exercise of stock options	$ 484		484
Exercise of stock options, shares		32,000
Stock-based compensation	8,096		8,096
Comprehensive loss	1,417			1,417
Net Income (Loss)	(45,995)				(45,995)
Ending Balance at Mar. 31, 2023	280,330		768,012	(2,514)	(485,168)
Ending Balance, Shares at Mar. 31, 2023		53,990,000
Beginning Balance at Dec. 31, 2023	539,106		1,191,831	977	(653,702)
Beginning Balance, Shares at Dec. 31, 2023		68,175,000
Issuance of common stock, net of transaction costs, shares		9,557,000
Issuance of common stock, net of transaction costs, value	$ 378,890		378,890
Stock issued under Employee Stock Purchase Plan, shares	0
Issuance of common stock upon vesting of restricted stock units shares		202,000
Exercise of stock options	$ 11,240		11,240
Exercise of stock options, shares	605,083	605,000
Stock-based compensation	$ 13,454		13,454
Comprehensive loss	(827)			(827)
Net Income (Loss)	(66,930)				(66,930)
Ending Balance at Mar. 31, 2024	$ 874,933		$ 1,595,415	$ 150	$ (720,632)
Ending Balance, Shares at Mar. 31, 2024		78,539,000